Four California counties are demanding $50 billion from Johnson & Johnson, Teva Pharmaceutical Industries, Endo International Plc, and Allergan Plc for their roles in marketing and distributing powerful opioid narcotics throughout their communities. And, as thousands of other municipalities and localities wait to have their own days in court to hold pharmaceutical manufacturers responsible, both sides are paying very close attention to what happens in the California ...
All Eyes on California as $50 Billion Opioid Trial Sets Stage for What’s to Come
Posted June 9, 2021 in Drug and Medical Device Lawsuits | Product News and Recalls
Three New Deaths Attributed to Cancer Tied to Breast Implants
Posted September 9, 2020 in Product News and Recalls
The death toll formally attributed to breast implant-associated anaplastic large cell lymphoma now stands at 36, although it could be higher. Three new fatalities have occurred within the same six months and just weeks before the implants implicated in the deaths were set to be recalled.
The implants in question were made by Allergan prior to its acquisition by AbbVie. The Biocell textured ...
continue reading...Lawsuit Alleges Textured Breast Implant Cancer Risk Coverup at Allergan
Posted April 6, 2020 in Drug and Medical Device Lawsuits | Product Liability | Product News and Recalls
Much of the initial concern over textured breast implant associated cases of anaplastic large cell lymphoma started out focused on non-U.S. markets. While the vast majority of U.S.-based breast implant procedures utilize smooth implants, the opposite held true for much of the rest of the market.
Six U.S. women who had textured breast implants used in their augmentation procedures have sued Allergan over their increased cancer risk and allege ...
continue reading...Breast Implant Cancer Cases Will Go to Multidistrict Litigation
Posted January 14, 2020 in Product News and Recalls
Approximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
The extraordinarily rare cancer first became ...
continue reading...As Women Call for Action, FDA Continues “Assessment” of Breast Implant Cancer Risk
Posted June 13, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls
A growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.
16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. ...
continue reading...IBS-D Drug Could Threaten Patient Safety after Single Day’s Use
Posted October 12, 2017 in Drug and Medical Device Lawsuits | Product News and Recalls
For those who suffer from irritable bowel syndrome with diarrhea, or IBS-D, the trouble is two-fold. Physically, they endure severe abdominal pain and possible nausea on a regular basis, as well as excessive amounts of gas and sudden urges to reach the nearest bathroom. But they also face potential embarrassment over their condition and can suffer anxiety and loss of appetite. These social aspects can have dramatic impacts on their quality ...
